Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 10
- Registration Number
- NCT03960268
- Locations
- πΊπΈ
Rockefeller Unviersity, New York, New York, United States
First-in-human Study of 10-1074-LS Alone and in Combination With 3BNC117-LS
- First Posted Date
- 2018-06-13
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 77
- Registration Number
- NCT03554408
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
3BNC117 and 10-1074 in ART-treated Individuals
- Conditions
- Human Immunodeficiency Virus
- Interventions
- First Posted Date
- 2018-05-16
- Last Posted Date
- 2022-02-15
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 26
- Registration Number
- NCT03526848
- Locations
- πΊπΈ
Ragon Institute of MGH, MIT, and Harvard, Boston, Massachusetts, United States
πΊπΈThe Rockefeller University, New York, New York, United States
Weight Loss Using a Feedback Device in Obese People With the Metabolic Syndrome
- Conditions
- Pre-DiabetesWeight LossObesityMetabolic Syndrome
- Interventions
- Device: VA MOVE! Coach appBehavioral: Standard of Care for weight loss.Behavioral: Telephone Coaching
- First Posted Date
- 2018-04-09
- Last Posted Date
- 2018-10-24
- Lead Sponsor
- Rockefeller University
- Registration Number
- NCT03491930
- Locations
- πΊπΈ
Rockefeller University, New York, New York, United States
Yellow Fever Immune Response at Single Cell Resolution
- First Posted Date
- 2018-03-08
- Last Posted Date
- 2019-11-08
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 6
- Registration Number
- NCT03458780
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
Effects of Dietary Fructose on Gut Microbiota and Fecal Metabolites in Obese Men and Postmenopausal Women: A Pilot Study
- Conditions
- ObesityNon-Alcoholic Fatty Liver Disease
- Interventions
- Other: Fructose Solution (75 Grams)Other: Glucose Solution (75 grams)
- First Posted Date
- 2017-11-13
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 13
- Registration Number
- NCT03339245
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
3BNC117-LS First-in-Human Phase 1 Study
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 43
- Registration Number
- NCT03254277
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
Impact of Narrowband UVB Phototherapy on Systemic Inflammation in Patients With Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Other: Narrow band UVB treatment (NB-UVB)
- First Posted Date
- 2017-03-20
- Last Posted Date
- 2020-02-26
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 6
- Registration Number
- NCT03083730
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
Romidepsin Plus 3BNC117 Phase 2a Study
- Conditions
- Human Immunodeficiency Virus (HIV)
- Interventions
- First Posted Date
- 2016-07-29
- Last Posted Date
- 2022-07-14
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 48
- Registration Number
- NCT02850016
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
π©π°Aarhus University Hospital, Aarhus, Denmark
π©πͺUniversity of Cologne, Cologne, Germany
3BNC117 and 10-1074 in HIV-infected Individuals
- Conditions
- Human Immunodeficiency Virus (HIV)
- Interventions
- First Posted Date
- 2016-07-07
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 34
- Registration Number
- NCT02825797
- Locations
- πΊπΈ
The Rockefeller University, New York, New York, United States
π©πͺUniversity Hospital of Cologne, Cologne, Germany